
In Suk C. Bullock
Supervisory Patent Examiner (ID: 15423, Phone: (571)272-5954 , Office: P/1772 )
| Most Active Art Unit | 1764 |
| Art Unit(s) | 1797, 1106, 1772, 1764 |
| Total Applications | 717 |
| Issued Applications | 452 |
| Pending Applications | 77 |
| Abandoned Applications | 190 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4826827
[patent_doc_number] => 20080125371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)'
[patent_app_type] => utility
[patent_app_number] => 11/504217
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7201
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125371.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504217 | Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) | Aug 14, 2006 | Abandoned |
Array
(
[id] => 5189054
[patent_doc_number] => 20070167363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)'
[patent_app_type] => utility
[patent_app_number] => 11/504526
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7203
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504526 | Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) | Aug 14, 2006 | Abandoned |
Array
(
[id] => 5160411
[patent_doc_number] => 20070173455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)'
[patent_app_type] => utility
[patent_app_number] => 11/504224
[patent_app_country] => US
[patent_app_date] => 2006-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7199
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173455.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504224
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504224 | Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP) | Aug 13, 2006 | Abandoned |
Array
(
[id] => 5688278
[patent_doc_number] => 20060286593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Transforming Growth Factor Alpha HI'
[patent_app_type] => utility
[patent_app_number] => 11/464386
[patent_app_country] => US
[patent_app_date] => 2006-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13723
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286593.pdf
[firstpage_image] =>[orig_patent_app_number] => 11464386
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/464386 | Transforming Growth Factor Alpha HI | Aug 13, 2006 | Abandoned |
Array
(
[id] => 5446014
[patent_doc_number] => 20090047240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'CHAPERONIN 10-INDUCED IMMUNOMODULATION'
[patent_app_type] => utility
[patent_app_number] => 11/995524
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 25316
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047240.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995524 | Chaperonin 10-induced immunomodulation | Jul 10, 2006 | Issued |
Array
(
[id] => 62607
[patent_doc_number] => 07763437
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-07-27
[patent_title] => 'Methods for identifying compounds that regulate β-Arrestin signaling complexes'
[patent_app_type] => utility
[patent_app_number] => 11/482277
[patent_app_country] => US
[patent_app_date] => 2006-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2525
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/763/07763437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11482277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/482277 | Methods for identifying compounds that regulate β-Arrestin signaling complexes | Jul 6, 2006 | Issued |
Array
(
[id] => 5204956
[patent_doc_number] => 20070026437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Novel BMP products'
[patent_app_type] => utility
[patent_app_number] => 11/472281
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14433
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472281 | Novel BMP products | Jun 21, 2006 | Abandoned |
Array
(
[id] => 5888893
[patent_doc_number] => 20060275868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Fusion proteins comprising tumor necrosis factor receptor'
[patent_app_type] => utility
[patent_app_number] => 11/451450
[patent_app_country] => US
[patent_app_date] => 2006-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20973
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11451450
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/451450 | Fusion proteins comprising tumor necrosis factor receptor | Jun 12, 2006 | Abandoned |
Array
(
[id] => 5760660
[patent_doc_number] => 20060211605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Mucosal repair by TFF dimer peptides'
[patent_app_type] => utility
[patent_app_number] => 11/439690
[patent_app_country] => US
[patent_app_date] => 2006-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7887
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211605.pdf
[firstpage_image] =>[orig_patent_app_number] => 11439690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/439690 | Mucosal repair by TFF dimer peptides | May 22, 2006 | Abandoned |
Array
(
[id] => 103088
[patent_doc_number] => 07723473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Peptide antagonists of TGF-beta family members and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/432125
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 12590
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723473.pdf
[firstpage_image] =>[orig_patent_app_number] => 11432125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/432125 | Peptide antagonists of TGF-beta family members and therapeutic uses thereof | May 10, 2006 | Issued |
Array
(
[id] => 5398275
[patent_doc_number] => 20090318338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'METHODS FOR MODULATING BONE FORMATION AND MINERALIZATION BY MODULATING KRC ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 11/918503
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43940
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318338.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918503
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918503 | Methods for modulating bone formation and mineralization by modulating KRC activity | Apr 13, 2006 | Issued |
Array
(
[id] => 5667041
[patent_doc_number] => 20060172391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'BMP-11 compositions'
[patent_app_type] => utility
[patent_app_number] => 11/401228
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12868
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172391.pdf
[firstpage_image] =>[orig_patent_app_number] => 11401228
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/401228 | BMP-11 compositions | Apr 10, 2006 | Abandoned |
Array
(
[id] => 5586261
[patent_doc_number] => 20090105463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Compositions of and Methods of Using Oversulfated Glycosaminoglycans'
[patent_app_type] => utility
[patent_app_number] => 11/887559
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 39340
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105463.pdf
[firstpage_image] =>[orig_patent_app_number] => 11887559
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/887559 | Compositions of and Methods of Using Oversulfated Glycosaminoglycans | Mar 28, 2006 | Abandoned |
Array
(
[id] => 5546600
[patent_doc_number] => 20090156477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Compositions and Methods for Regulating Inflammatory Responses'
[patent_app_type] => utility
[patent_app_number] => 11/887561
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27578
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156477.pdf
[firstpage_image] =>[orig_patent_app_number] => 11887561
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/887561 | Compositions and Methods for Regulating Inflammatory Responses | Mar 28, 2006 | Abandoned |
Array
(
[id] => 5322879
[patent_doc_number] => 20090060869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE'
[patent_app_type] => utility
[patent_app_number] => 11/908600
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9903
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908600
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908600 | EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE | Mar 27, 2006 | Abandoned |
Array
(
[id] => 5700625
[patent_doc_number] => 20060217310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Fibroblast growth factor 1 (FGF-1) used for skin care'
[patent_app_type] => utility
[patent_app_number] => 11/387051
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5721
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217310.pdf
[firstpage_image] =>[orig_patent_app_number] => 11387051
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/387051 | Fibroblast growth factor 1 (FGF-1) used for skin care | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5324202
[patent_doc_number] => 20090062192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Dimeric Peptide Agonists of the Glp-1 Receptor'
[patent_app_type] => utility
[patent_app_number] => 11/908835
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14798
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062192.pdf
[firstpage_image] =>[orig_patent_app_number] => 11908835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/908835 | Dimeric Peptide Agonists of the Glp-1 Receptor | Mar 19, 2006 | Abandoned |
Array
(
[id] => 5259109
[patent_doc_number] => 20070212741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Diagnostic markers for sub-acute ruminal acidosis'
[patent_app_type] => utility
[patent_app_number] => 11/372170
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11985
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212741.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372170
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372170 | Diagnostic markers for sub-acute ruminal acidosis | Mar 9, 2006 | Abandoned |
Array
(
[id] => 5632580
[patent_doc_number] => 20060149050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Isolation and method of using tissue growth-inducing Frzb'
[patent_app_type] => utility
[patent_app_number] => 11/369089
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14615
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20060149050.pdf
[firstpage_image] =>[orig_patent_app_number] => 11369089
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/369089 | Isolation and method of using tissue growth-inducing Frzb | Mar 5, 2006 | Abandoned |
Array
(
[id] => 32490
[patent_doc_number] => 07785579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Modified tumor necrosis factor'
[patent_app_type] => utility
[patent_app_number] => 11/363863
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5845
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11363863
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/363863 | Modified tumor necrosis factor | Feb 26, 2006 | Issued |